Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6
Phase of Trial: Phase III
Latest Information Update: 17 Nov 2014
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Pharmacogenomic; Therapeutic Use
- 30 Sep 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2013 Planned number of patients changed from 350 to 500 as reported by ClinicalTrials.gov.